Vital Signs July-August 2021 PDF

7/23/2021

/Publications/Vital-Signs---Member-Publication/Vital-Signs-July-August-2021-PDF/

Testimony in Support of H.729, An Act to Ensure Prescription Drug Cost Transparency and Affordability and S.771, An Act Relative to Pharmaceutical Access, Costs and Transparency

7/13/2021

into account, the benefits of these rebates are largely consumed by PBMs, so they are not savings for our …

/Advocacy/State-Advocacy/State-Testimony/Testimony-in-Support-of-H-729,-An-Act-to-Ensure-Prescription-Drug-Cost-Transparency-and-Affordability-and-S-771,-An-Act-Relative-to-Pharmaceutical-Access,-Costs-and-Transparency/

Testimony in Support of H.729 and S.771 Before the Joint Committee on Health Care Financing (PDF)

7/13/2021

of these rebates are largely consumed by PBMs, so they are not savings for our health care system, nor …

/Advocacy/State-Advocacy/State-Testimony/Testimony-in-Support-of-H-729-and-S-771-Before-the-Joint-Committee-on-Health-Care-Financing-(PDF)/

Testimony Relative to H.2411, An Act Relative to Vaccinations and Preventing Future Disease Outbreaks, and S.1517 and H.2271, An Act Promoting Community Immunity

7/12/2021

vaccination rates began falling long before COVID, largely due to increases in non-medical vaccination …

/Advocacy/State-Advocacy/State-Testimony/Testimony-Relative-to-H-2411,-An-Act-Relative-to-Vaccinations-and-Preventing-Future-Disease-Outbreaks,-and-S-1517-and-H-2271,-An-Act-Promoting-Community-Immunity/

Testimony Relative to H.2411, S.1517 and H.2271 Before the Joint Committee on Public Health Care (PDF)

7/12/2021

falling long before COVID, largely due to increases in non-medical vaccination exemptions. Over the past …

/Advocacy/State-Advocacy/State-Testimony/Testimony-Relative-to-H-2411,-S-1517-and-H-2271-Before-the-Joint-Committee-on-Public-Health-Care-(PDF)/

Comments Regarding Out-of-Network Billing (PDF)

7/2/2021

billing disputes, with the potential outcomes of such a program largely speculative and highly debated …

/Advocacy/State-Advocacy/State-Regulatory-Comments/Comments-Regarding-Out-of-Network-Billing-(PDF)/

Testimony in Support of H.1197 and S.680, An Act Relative to Out-of-Network Billing Before the Joint Committee on Financial Services (PDF)

7/2/2021

of such a program largely speculative and highly debated. If such a task were to be undertaken, however …

/Advocacy/State-Advocacy/State-Testimony/Testimony-in-Support-of-H-1197-and-S-680,-An-Act-Relative-to-Out-of-Network-Billing-Before-the-Joint-Committee-on-Financial-Services-(PDF)/

Testimony in Support of H.1197 and S.680, An Act Relative to Out-of-Network Billing Before the Joint Committee on Financial Services

7/1/2021

disputes, with the potential outcomes of such a program largely speculative and highly debated …

/Advocacy/State-Advocacy/State-Testimony/Testimony-in-Support-of-H-1197-and-S-680,-An-Act-Relative-to-Out-of-Network-Billing-Before-the-Joint-Committee-on-Financial-Services/

Comments Regarding Out-of-Network Billing

6/30/2021

outcomes of such a program largely speculative and highly debated. Instead, Massachusetts can use …

/Advocacy/State-Advocacy/State-Regulatory-Comments/Comments-Regarding-Out-of-Network-Billing/

Committee on Global Health - June 30, 2021

6/30/2021

/Governance-and-Leadership/Committees,-Task-Forces-and-Sections/Committee-on-Global-Health---June-30,-2021/